BioCentury
ARTICLE | Regulation

China and Japan raise the bar on expedited approvals, adding time limits

Iterating on FDA, EMA expedited approvals with stricter requirements for postmarket data submissions

September 2, 2021 1:21 PM GMT
Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article